RFK Jr. takes shortcut to make some unapproved peptides available for use
The Trump administration will allow pharmacies to make and sell popular peptide injections, utilizing a shortcut that grants broad access to unapproved products. Health Secretary RFK Jr. unilaterally authorized availability for the compounds, overriding the Food and Drug Administration. The decision cheered gray-market peptide vendors and compounding pharmacies, while bypassing standard federal drug safety evaluations. Studies show rising use of untested compounds like the Wolverine peptide, often obtained through compounding pharmacies or alternative vendors to manage pain and gastrointestinal symptoms.
Listen to Live Briefing
Real-time synthesized voice briefing · Live Feeds Desk
- ✓ The Trump administration will allow pharmacies to make popular peptides.
- ✓ RFK Jr. is allowing the broad use of unapproved peptide injections.
- ✓ The U.S. health department will allow the temporary sale of some unapproved peptides.
- ✓ RFK Jr. unilaterally granted access, overruling the FDA.
What changed
Health Secretary RFK Jr. bypassed the Food and Drug Administration to unilaterally grant broad access to unapproved peptide injections.
Live updates
-
RFK Jr. Overrules FDA to Allow Sale of Unapproved Peptides
The Trump administration will allow pharmacies to make and sell popular peptide injections, utilizing a shortcut that grants broad access to unapproved products. Health Secretary RFK Jr. unilaterally authorized availability for the compounds, overriding the Food and Drug Administration. The decision cheered gray-market peptide vendors and compounding pharmacies, while bypassing standard federal drug safety evaluations. Studies show rising use of untested compounds like the Wolverine peptide, often obtained through compounding pharmacies or alternative vendors to manage pain and gastrointestinal symptoms.
Why it matters
The Food and Drug administration normally regulates injectable peptides for safety and efficacy before market entry. Bypassing these regulatory channels introduces compounds directly to consumers without standard oversight. Public health analysts continue to track the rising popularity of these substances outside traditional medical channels.
What is confirmed
- The Trump administration will allow pharmacies to make popular peptides.
- RFK Jr. is allowing the broad use of unapproved peptide injections.
- The U.S. health department will allow the temporary sale of some unapproved peptides.
- RFK Jr. unilaterally granted access, overruling the FDA.
What to watch next
- Official guidance or timelines from the U.S. health department regarding the temporary sale of unapproved peptides
- Response or enforcement actions from the Food and Drug Administration regarding the policy override
- Compounding pharmacy production volume changes for popular peptide compounds
confidence 100%Sources used for this update (13)
- kffhealthnews.org — KFF Health News
- www.nbcnews.com — NBC News - Breaking Headlines and Video Reports on World, U.S....
- flipboard.com — Beloved singer’s wife killed after welcoming robbery suspects with lemonade
- NBC News — RFK Jr. takes shortcut to make some peptides more widely available
- The New York Times — RFK Jr. to Allow Broad Use of Unapproved Peptide Injections
- Reuters — US health department to allow temporary sale of some unapproved peptides
- NPR — Trump administration will allow pharmacies to make popular peptides
- Ars Technica — Peptide peddlers cheer as RFK Jr. unilaterally grants access, overruling FDA
- cashwalklabs.io — GM will switch to Nasdaq from the NYSE on Nov. 17
- www.theguardian.com — RFK Jr assailed over ‘wildly racist tirade’ about Arabs at ...
- roanoke.com — Use of untested 'Wolverine' peptide backed by RFK Jr. on the rise, study finds
- en.wikipedia.org — Robert F. Kennedy - Wikipedia
Community Sentiment: How do you assess this situation?
Voice your perspective · Real-time aggregated sentiment from the Live Feeds community